Paradox Immunotherapeutics
PrivateLast Round
Seed
Feb 25, 2025
Total Funding Raised
$10M
Company Overview
Paradox Immunotherapeutics is a biotechnology company developing monoclonal antibody therapies for the treatment of rare protein misfolding diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paradox Immunotherapeutics Comparables
Compare Paradox Immunotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Attralus | 78% | |
| AstraZeneca | 73% | |
| Prothena Corporation plc | 72% |
Paradox Immunotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 25, 2025 |
Key People
Founding team and executive leadership
Paradox Immunotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2025
$10M raised in early funding.
- Feb 25, 2025
Selected for the Springboard Enterprises Life Sciences Program.
Paradox Immunotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Paradox Immunotherapeutics's valuation, stock price, and market status.
Is Paradox Immunotherapeutics a public or private company?
Paradox Immunotherapeutics is a private company.
What is the current stock price of Paradox Immunotherapeutics?
Paradox Immunotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Paradox Immunotherapeutics worth (valuation)?
Valuation information for Paradox Immunotherapeutics is not publicly available.
Can I buy Paradox Immunotherapeutics stock?
Paradox Immunotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Paradox Immunotherapeutics's last funding round?
Paradox Immunotherapeutics's most recent funding round was Early Funding on February 25, 2025.
Who are the main investors in Paradox Immunotherapeutics?
Key investors in Paradox Immunotherapeutics include SymBiosis Capital Management.
Will Paradox Immunotherapeutics IPO soon?
No public IPO plans have been announced for Paradox Immunotherapeutics.
How can I track Paradox Immunotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Paradox Immunotherapeutics's secondary market activity and sign up for updates.